European Journal of Surgical Oncology
Volume 33, Issue 4 , Pages 452-458 , May 2007

Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer

  • M. Vermaas

      Affiliations

    • Department of Surgical Oncology, Erasmus MC – Daniel den Hoed Cancer Center, P.O. Box 5201, 3008 AE Rotterdam, The Netherlands
    • ,
  • F.T.J. Ferenschild

      Affiliations

    • Department of Surgical Oncology, Erasmus MC – Daniel den Hoed Cancer Center, P.O. Box 5201, 3008 AE Rotterdam, The Netherlands
    • ,
  • C. Verhoef

      Affiliations

    • Department of Surgical Oncology, Erasmus MC – Daniel den Hoed Cancer Center, P.O. Box 5201, 3008 AE Rotterdam, The Netherlands
    • ,
  • J.J.M.E. Nuyttens

      Affiliations

    • Department of Radiotherapy, Erasmus MC – Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • A.W.K.S. Marinelli

      Affiliations

    • Department of Surgical Oncology, Erasmus MC – Daniel den Hoed Cancer Center, P.O. Box 5201, 3008 AE Rotterdam, The Netherlands
    • Present address: Medisch Centrum Haaglanden, Den Haag, The Netherlands.
    • ,
  • T. Wiggers

      Affiliations

    • Department of Surgical Oncology, Erasmus MC – Daniel den Hoed Cancer Center, P.O. Box 5201, 3008 AE Rotterdam, The Netherlands
    • Present address: Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands.
    • ,
  • W.J. Kirkels

      Affiliations

    • Department of Urology, Erasmus MC – Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • A.M.M. Eggermont

      Affiliations

    • Department of Surgical Oncology, Erasmus MC – Daniel den Hoed Cancer Center, P.O. Box 5201, 3008 AE Rotterdam, The Netherlands
    • ,
  • J.H.W. de Wilt

      Affiliations

    • Department of Surgical Oncology, Erasmus MC – Daniel den Hoed Cancer Center, P.O. Box 5201, 3008 AE Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 10 4391232; fax: +31 10 4391011.

,Accepted 21 September 2006.

References 

  1. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–646
  2. Wanebo HJ, Antoniuk P, Koness RJ, et al. Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum. 1999;42(11):1438–1448
  3. Saito N, Koda K, Takiguchi N, et al. Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg. 2003;20(3):192–200
  4. Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg. 2003;237(4):502–508
  5. Vermaas M, Ferenschild FT, Nuyttens JJ, et al. Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum. 2005;48(5):918–928
  6. Luna-Perez P, Delgado S, Labastida S, Ortiz N, Rodriguez D, Herrera L. Patterns of recurrence following pelvic exenteration and external radiotherapy for locally advanced primary rectal adenocarcinoma. Ann Surg Oncol. 1996;3(6):526–533
  7. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. Cancer. 1948;1:177
  8. Law WL, Chu KW, Choi HK. Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg. 2000;190(1):78–83
  9. Shirouzu K, Isomoto H, Kakegawa T. Total pelvic exenteration for locally advanced colorectal carcinoma. Br J Surg. 1996;83(1):32–35
  10. Nakafusa Y, Tanaka T, Tanaka M, Kitajima Y, Sato S, Miyazaki K. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum. 2004;47(12):2055–2063
  11. Ike H, Shimada H, Yamaguchi S, Ichikawa Y, Fujii S, Ohki S. Outcome of total pelvic exenteration for primary rectal cancer. Dis Colon Rectum. 2003;46(4):474–480
  12. Moriya Y, Akasu T, Fujita S, Yamamoto S. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer. Surg Oncol Clin N Am. 2005;14(2):225–238
  13. Wydra D, Emerich J, Sawicki S, Ciach K, Marciniak A. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience. World J Gastroenterol. 2006;12(7):1115–1119
  14. Yamada K, Ishizawa T, Niwa K, Chuman Y, Aikou T. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum. 2002;45(8):1078–1084
  15. Kecmanovic DM, Pavlov MJ, Kovacevic PA, Sepetkovski AV, Ceranic MS, Stamenkovic AB. Management of advanced pelvic cancer by exenteration. Eur J Surg Oncol. 2003;29(9):743–746
  16. Hanssens PEJ, Kolkman-Deurloo IKK, Wijnmaalen AJ, et al. Intraoperative HDR brachytherapy (IO-HDR-BT) using a flexible intraoperative template (FIT) in the multidisciplinary treatment of locally advanced rectal cancer. Radiother Oncol. 1998;48:S169–S666
  17. Wiig JN, Poulsen JP, Larsen S, Braendengen M, Waehre H, Giercksky KE. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Eur J Surg. 2002;168(1):42–48
  18. Chan AK, Wong AO, Langevin J, et al. Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study. Int J Radiat Oncol Biol Phys. 2000;48(3):843–856
  19. Rutten HJ, Mannaerts GH, Martijn H, Wiggers T. Intraoperative radiotherapy for locally recurrent rectal cancer in The Netherlands. Eur J Surg Oncol. 2000;26(Suppl. A):S16–S20
  20. Rodel C, Grabenbauer GG, Matzel KE, et al. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum. 2000;43(3):312–319
  21. Lopez MJ, Standiford SB, Skibba JL. Total pelvic exenteration. A 50-year experience at the Ellis Fischel Cancer Center. Arch Surg. 1994;129(4):390–395discussion 395–6
  22. Marijnen CA, Kapiteijn E, van de Velde CJ, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2002;20(3):817–825
  23. Gunderson LL, Nelson H, Martenson JA, et al. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer. Dis Colon Rectum. 1996;39(12):1379–1395
  24. Ferenschild FTJ, Vermaas M, Nuyttens JJME, et al. Value of intraoperative radiotherapy in locally advanced rectal cancer. Dis Colon Rectum. 2006;49:1257–1265
  25. Hashiguchi Y, Sekine T, Sakamoto H, et al. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum. 1999;42(7):886–893discussion 893–5
  26. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol. 2002;26(3):350–357
  27. Beets-Tan RG, Beets GL, Borstlap AC, et al. Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI?. Abdom Imaging. 2000;25(5):533–541
  28. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–1740
  29. Nuyttens JJ, Robertson JM, Yan D, Martinez A. The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer. Cancer Radiother. 2004;8(5):297–304

PII: S0748-7983(06)00349-0

doi: 10.1016/j.ejso.2006.09.021

European Journal of Surgical Oncology
Volume 33, Issue 4 , Pages 452-458 , May 2007

Article Tools

* Image Usage & Resolution